FDA allows Curis to resume testing cancer drug
(Reuters) - Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing its experimental cancer drug, lifting a November order h...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/gE0RB30N5As/story01.htm
No comments:
Post a Comment